MIRA
INFORM REPORT
|
Report Date : |
23.08.2014 |
IDENTIFICATION DETAILS
|
Name : |
ZENARA PHARMA PRIVATE LIMITED (w.e.f. 23.07.2008) |
|
|
|
|
Formerly Known
As : |
DANMED PHARMACEUTICALS PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Plot No. 87-95, Phase-III, IDA, Cherlapally, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2013 |
|
|
|
|
Date of
Incorporation : |
18.03.2004 |
|
|
|
|
Com. Reg. No.: |
01-042894 |
|
|
|
|
Capital Investment
/ Paid-up Capital : |
Rs. 334.934 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24239TG2004PTC042894 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
HYDD01366B |
|
|
|
|
PAN No.: [Permanent Account No.] |
AABCD9399K |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer of Drug Formulations for Nicotine Replacement
Therapy. |
|
|
|
|
No. of Employees
: |
Not Available [We tried to confirm
the number of employees but no one is ready to part any information from the
company management] |
RATING & COMMENTS
|
MIRA’s Rating : |
B (30) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 1000000 |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having a moderate track record.
There appears accumulated losses recorded by the company. However, trade relations are reported to be fair. Business is active.
Payments are reported to be slow but correct. The company can be considered for business dealings with some caution.
|
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 1, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INDIAN ECONOMIC OVERVIEW
N E W S
As per the latest IMF study, the total weigh of emerging markets in the GDP
of the world on a purchasing power parity basis has seen a sizeable shift. It
highlights how as against 51 % in 2005, the emerging economies now account for
close to 56 % of the global purchasing power GDP as per the latest survey. And
with the emerging economies growing at a faster rate than their developed
counterparts, there are every possibility that the their share goes up further
in the coming years. China may surpass the US over the next few years.
Politics and economics are very intricately connected. They tend to
influence each other in ways that could be very complex and far-reaching. The
prospects of the India’s economy have been seriously compromised due to
political corruption. High inflation, poor standard of living are to a great
extent a result of rampant corruption in the country. China on the other hand,
seems to be facing diametrically opposite challenge. American hedge fund
manager Jim Chanos has been keenly following the political and economic
development in the dragon economy and has figured out something that is quite
worrying. He is of the view that the Chinese economy could be heading toward
trouble on account of new Chinese President Xi Jingping’s very aggressive
anti-corruption drive. Chanos believes tat many things such as apartment sales,
luxury products, etc. were largely bought with dirty money. And it is now
beginning to impact consumption. This may indeed be bad news for an economy
that is struggling to transition from an investment-driven export-oriented
economy to a domestic consumption-driven economy.
A study published by Firstpost has revealed that asset classes like real
estate and equities were the biggest beneficiaries of the liberalization
policies. A firm called Ciane Analytics studied returns from assets
including equities, gold, fixed deposits, G-Secs and real estate since 1991.
Real estate outperformed every other asset classes during the 23-year period
with an annualized return of 20 % ! Equities came in second with annualized
return of 15.5 % ! However, while these returns may seem mouthwatering, the
fact is that the return from equities adjusted for inflation came down to just
7.1 %.
Some brief news are as under
. R-Power to buy Jaypee’s hydro assets
. Investors await justice in NSEL case
. India seeks MFN status from Pakistan ahead of meeting
. Ukrain’s clashes with rebels hinder MH17 crash investigation
. India exploring merger of state-owned hydro PSUs
..Higher costs weigh down profit growth to slowest in 9 quarters
..Wal-Mart to expand wholesale business in India
. GMR group moves to strengthen balance sheet
. Central Bank to sell 4 % stake to Life Insurance Corporation
. Tata Chemicals plans to raise up to Rs 10000 mn.
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2014.
INFORMATION DECLINED
Management Non – Cooperative (91-40-27260848)
LOCATIONS
|
Registered Office / Corporate Office : |
Plot No. 87-95, Phase-III, IDA, Cherlapally, Hyderabad – 500051,
Telangana, India |
|
Tel. No.: |
91-40-27260848 |
|
Mobile No.: |
91-9703049798 (Mr. Krishna Prasad) |
|
Fax No.: |
91-40-27290849 |
|
E-Mail : |
|
|
Website : |
DIRECTORS
As on 28.09.2013
|
Name : |
Mr. Ashok Narasimhan |
|
Designation : |
Director |
|
Address : |
55, ELM Drive, North Harrow – HA27BY, United Kingdom, India |
|
Date of Birth/Age : |
17.07.1955 |
|
Date of Appointment : |
28.09.2012 |
|
DIN No.: |
02333924 |
|
|
|
|
Name : |
Mr. William Merwin Haskel |
|
Designation : |
Director |
|
Address : |
93, Bernard Drive, Basking Ridge, New Jersey – 0719202695, United
States of America, India |
|
Date of Birth/Age : |
25.03.1961 |
|
Date of Appointment : |
15.05.2012 |
|
DIN No.: |
03620379 |
|
|
|
|
Name : |
Mr. Gregory Paul Sargen |
|
Designation : |
Director |
|
Address : |
26, Crest Drive, Basking Ridge, New Jersey – 0719202695, United States
of America, India |
|
Date of Birth/Age : |
16.06.1965 |
|
Date of Appointment : |
15.05.2012 |
|
DIN No.: |
03620384 |
|
|
|
|
Name : |
Mr. Steven Mark Klosk |
|
Designation : |
Director |
|
Address : |
852, High Woods DR, Franklin Lakes, New Jersey – 074172257, United States
of America, India |
|
Date of Birth/Age : |
02.03.1957 |
|
Date of Appointment : |
15.05.2012 |
|
DIN No.: |
03620382 |
|
|
|
|
Name : |
Mr. Raghavan Grs |
|
Designation : |
Director |
|
Address : |
C 2, Lakeview Apartments Road No. 11, Banjara Hills, Hyderabad –
500034, Andhra Pradesh, India |
|
Date of Birth/Age : |
23.08.1965 |
|
Date of Appointment : |
13.12.2012 |
|
DIN No.: |
01855204 |
KEY EXECUTIVES
|
Name : |
Mrs. Harsha Wardhan Govindu |
|
Designation : |
Secretary |
|
Address : |
Flat No. 306, Carnation Block Ark Homes, Near Bolarum, Railway
Station, Bolarum, Secunderabad, Hyderabad – 500010, Andhra Pradesh,
India |
|
Date of Birth/Age : |
12.11.1983 |
|
Date of Appointment : |
09.07.2012 |
|
PAN No.: |
ABPPW2229P |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 28.09.2013
|
Names of Shareholders |
|
No. of Shares |
|
Camzena Holdings Limited, Mauritius
|
|
17082258 |
|
Nulife (Cyprus) Limited, Cyprus |
|
16411151 |
|
Zenara Pharma Limited, London |
|
10 |
|
Total |
|
33493419 |
Equity Share Break up (Percentage of Total Equity)
As on 28.09.2013
|
Category |
Percentage |
|
Foreign holdings( Foreign institutional
investor(s), Foreign companie(s) Foreign financial institution(s),
Non-resident Indian(s) or Overseas Corporate bodies or Others |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Drug Formulations for Nicotine Replacement
Therapy. |
GENERAL INFORMATION
|
No. of Employees : |
Not Available [We tried to
confirm the number of employees but no one is ready to part any information
from the company management] |
||||||||||||||||||
|
|
|
||||||||||||||||||
|
Bankers : |
The South Indian Bank Limited, Industrial Finance Branch, 110, Raheja
Towers, Anna Salai, Chennai – 600002, Tamil Nadu, India |
||||||||||||||||||
|
|
|
||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
|
|
|
|
|
Auditors : |
|
|
Name : |
Haribhakti and company Chartered Accountants |
|
Address : |
Star, 42, Free Press House, 215, Nariman Point, Mumbai – 400021, Maharashtra, India |
|
PAN N Income-tax PAN of auditor or auditor's firm : |
AAAFH2010F |
|
|
|
|
Holding company: |
· Camzena Holdings Limited, Mauritius |
|
|
|
|
Associates: |
· a.Zenara Pharma Limited(UK) |
CAPITAL STRUCTURE
As on 31.03.2013
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
38000000 |
Equity Shares |
Rs.10/- each |
Rs.380.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
33493419 |
Equity Shares |
Rs.10/- each |
Rs.334.934
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES
OF FUNDS |
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
|
|
|
|
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
334.934 |
334.934 |
334.934 |
|
(b) Reserves & Surplus |
(139.971) |
(75.736) |
(25.216) |
|
(c) Money received against
share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
194.963 |
259.198 |
309.718 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
0.834 |
0.000 |
0.000 |
|
(b) Deferred tax liabilities
(Net) |
0.000 |
0.000 |
0.000 |
|
(c) Other long term
liabilities |
72.595 |
10.349 |
5.950 |
|
(d) long-term provisions |
2.490 |
2.131 |
1.501 |
|
Total
Non-current Liabilities (3) |
75.919 |
12.480 |
7.451 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
0.076 |
0.000 |
0.000 |
|
(b) Trade payables |
3.887 |
3.620 |
16.666 |
|
(c) Other current liabilities |
17.940 |
10.670 |
18.638 |
|
(d) Short-term provisions |
2.672 |
1.537 |
0.000 |
|
Total
Current Liabilities (4) |
24.575 |
15.827 |
35.304 |
|
|
|
|
|
|
TOTAL |
295.457 |
287.505 |
352.473 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
191.586 |
186.483 |
193.972 |
|
(ii) Intangible Assets |
31.064 |
31.640 |
51.405 |
|
(iii) Capital work-in-progress |
23.821 |
18.893 |
0.000 |
|
(iv) Intangible assets under
development |
0.000 |
0.000 |
0.632 |
|
(b) Non-current Investments |
0.000 |
0.000 |
7.233 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
16.027 |
19.932 |
17.099 |
|
(e) Other Non-current assets |
0.000 |
0.000 |
7.929 |
|
Total
Non-Current Assets |
262.498 |
256.948 |
278.270 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
0.000 |
0.000 |
0.000 |
|
(b) Inventories |
22.534 |
14.174 |
15.531 |
|
(c) Trade receivables |
3.685 |
1.489 |
9.248 |
|
(d) Cash and cash equivalents |
0.401 |
10.447 |
45.128 |
|
(e) Short-term loans and
advances |
6.077 |
4.231 |
3.119 |
|
(f) Other current assets |
0.262 |
0.216 |
1.177 |
|
Total
Current Assets |
32.959 |
30.557 |
74.203 |
|
|
|
|
|
|
TOTAL |
295.457 |
287.505 |
352.473 |
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
|
SALES |
|
|
|
|
|
Income |
10.515 |
44.042 |
41.710 |
|
|
Other Income |
3.429 |
2.670 |
6.711 |
|
|
TOTAL
|
13.944 |
46.712 |
48.421 |
|
|
|
|
|
|
|
Less |
EXPENSES |
78.179 |
89.999 |
72.162 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX |
(64.235) |
(43.287) |
(23.741) |
|
|
|
|
|
|
|
Less |
TAX |
0.000 |
7.233 |
(24.336) |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) AFTER TAX |
(64.235) |
(50.520) |
0.595 |
|
|
|
|
|
|
|
|
Earnings
/ (Loss) Per Share (Rs.) |
(1.92) |
NA |
NA |
KEY RATIOS
|
PARTICULARS |
|
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
PAT / Total Income |
(%) |
(460.66) |
(108.15) |
1.23 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
(610.89) |
(98.29) |
(56.92) |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
(23.65) |
(16.12) |
(6.89) |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
(0.33) |
(0.17) |
(0.08) |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt /Networth) |
|
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.34 |
1.93 |
2.10 |
FINANCIAL ANALYSIS
[all figures are
in Rupees Millions]
DEBT EQUITY RATIO
|
Particular |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Share Capital |
334.934 |
334.934 |
334.934 |
|
Reserves & Surplus |
(25.216) |
(75.736) |
(139.971) |
|
Net
worth |
309.718 |
259.198 |
194.963 |
|
|
|
|
|
|
long-term borrowings |
0.000 |
0.000 |
0.834 |
|
Short term borrowings |
0.000 |
0.000 |
0.076 |
|
Total
borrowings |
0.000 |
0.000 |
0.910 |
|
Debt/Equity
ratio |
0.000 |
0.000 |
0.005 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Sales |
41.710 |
44.042 |
10.515 |
|
|
|
5.591 |
(76.125) |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Sales |
41.710 |
44.042 |
10.515 |
|
Profit |
0.595 |
(50.520) |
(64.235) |
|
|
1.43% |
(114.71%) |
(610.89%) |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
No |
|
9] |
Name of person contacted |
No |
|
10] |
Designation of contact
person |
No |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
-- |
|
14] |
Estimation for coming
financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details
(if applicable) |
No |
|
21] |
Market information |
-- |
|
22] |
Litigations that the firm
/ promoter involved in |
-- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking
account |
-- |
|
26] |
Buyer visit details |
-- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of
Proprietor/Partner/Director, if available |
No |
|
33] |
Voter ID No of Proprietor/Partner/Director,
if available |
No |
|
34] |
External Agency Rating,
if available |
No |
NOTE: Registered office of the company has been shifted from No.135, Siripuram Colony,Malakpet, Hyderabad – 500016, Andhra Pradesh, India to the present address w.e.f. 29.09.2006
INDEX OF CHARGES: NO CHARGES EXIST FOR COMPANY
FINANCIAL REVIEW
Many batches dispatched earlier were returned for repacking by Johnson and Johnson (per their specifications), our customer, and the credits for these were booked this year. Further, there have been no incremental orders and this, coupled with continuing operating costs and overheads, has resulted in lesser revenue and increased loss for the period.
BUSINESS REVIEW
Plans for increase of business are advancing, and with some orders coming in, there is optimism about the future. The Directors are exploring various additional ways to improve the Company’s business prospects. Plans for product diversification, new tie-ups and over-all improvement of internal processes are at an advanced stage. With the Indian economy showing no more than slow recovery, there is cautious optimism about the business prospects of the company. However, the Directors have faith in the fundamentals of the company and are aggressively working to maximize opportunities to jumpstart business.
BACKGROUND
Subject was incorporated on 18th March, 2004. The Company is presently engaged in the manufacture of drug formulations for Nicotine Replacement Therapy. The Company’s corporate office is located in Cherlapally, Hyderabad .
FIXED ASSETS
Tangible assets
· Land
· Buildings
· Plant and equipment
· Furniture and fixtures
· Vehicles
· Office equipment
· Computer equipments
Intangible assets
· Brands and trade marks
· Trade marks
· Patents
· Know-how
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or anti-terrorism
sanction laws or whose assets were seized, blocked, frozen or ordered forfeited
for violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.44 |
|
|
1 |
Rs.100.24 |
|
Euro |
1 |
Rs.80.35 |
INFORMATION DETAILS
|
Information Gathered
by : |
PRT |
|
|
|
|
Analysis Done by
: |
SUB |
|
|
|
|
Report Prepared
by : |
KVT |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
4 |
|
PAID-UP CAPITAL |
1~10 |
3 |
|
OPERATING SCALE |
1~10 |
4 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
3 |
|
--PROFITABILIRY |
1~10 |
3 |
|
--LIQUIDITY |
1~10 |
3 |
|
--LEVERAGE |
1~10 |
4 |
|
--RESERVES |
1~10 |
3 |
|
--CREDIT LINES |
1~10 |
3 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
30 |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.